<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_5Qeabj3">The influence of LncRNA H19 polymorphic variants on susceptibility to cancer: A systematic review and updated meta-analysis of 28 case-control studies</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">© 2021 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
				</availability>
				<date type="published" when="2021-07-26">July 26, 2021</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Kunpeng</forename><surname>Wang</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Urology , The First People&apos;s Hospital of Lianyungang , Lianyungang Clinical Medical College of Nanjing Medical University , Lianyungang , China ,</note>
								<orgName type="department" key="dep1">Department of Urology</orgName>
								<orgName type="department" key="dep2">Lianyungang Clinical Medical College</orgName>
								<orgName type="institution" key="instit1">The First People&apos;s Hospital of Lianyungang</orgName>
								<orgName type="institution" key="instit2">Nanjing Medical University</orgName>
								<address>
									<settlement>Lianyungang</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zheng</forename><surname>Zhu</surname></persName>
							<affiliation key="aff1">
								<note type="raw_affiliation"><label>2</label> First Clinical Medical College of Nanjing Medical University , Nanjing , China ,</note>
								<orgName type="department">First Clinical Medical College</orgName>
								<orgName type="institution">Nanjing Medical University</orgName>
								<address>
									<settlement>Nanjing</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yiqiu</forename><surname>Wang</surname></persName>
							<affiliation key="aff2">
								<note type="raw_affiliation"><label>3</label> Department of Surgical Oncology , Xuzhou Central Hospital , Southeast University Cancer Institute , Xuzhou , China</note>
								<orgName type="department">Department of Surgical Oncology</orgName>
								<orgName type="institution" key="instit1">Xuzhou Central Hospital</orgName>
								<orgName type="institution" key="instit2">Southeast University Cancer Institute</orgName>
								<address>
									<settlement>Xuzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dayuan</forename><surname>Zong</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Urology , The First People&apos;s Hospital of Lianyungang , Lianyungang Clinical Medical College of Nanjing Medical University , Lianyungang , China ,</note>
								<orgName type="department" key="dep1">Department of Urology</orgName>
								<orgName type="department" key="dep2">Lianyungang Clinical Medical College</orgName>
								<orgName type="institution" key="instit1">The First People&apos;s Hospital of Lianyungang</orgName>
								<orgName type="institution" key="instit2">Nanjing Medical University</orgName>
								<address>
									<settlement>Lianyungang</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Peng</forename><surname>Xue</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Urology , The First People&apos;s Hospital of Lianyungang , Lianyungang Clinical Medical College of Nanjing Medical University , Lianyungang , China ,</note>
								<orgName type="department" key="dep1">Department of Urology</orgName>
								<orgName type="department" key="dep2">Lianyungang Clinical Medical College</orgName>
								<orgName type="institution" key="instit1">The First People&apos;s Hospital of Lianyungang</orgName>
								<orgName type="institution" key="instit2">Nanjing Medical University</orgName>
								<address>
									<settlement>Lianyungang</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jinbao</forename><surname>Gu</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Urology , The First People&apos;s Hospital of Lianyungang , Lianyungang Clinical Medical College of Nanjing Medical University , Lianyungang , China ,</note>
								<orgName type="department" key="dep1">Department of Urology</orgName>
								<orgName type="department" key="dep2">Lianyungang Clinical Medical College</orgName>
								<orgName type="institution" key="instit1">The First People&apos;s Hospital of Lianyungang</orgName>
								<orgName type="institution" key="instit2">Nanjing Medical University</orgName>
								<address>
									<settlement>Lianyungang</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daoyuan</forename><surname>Lu</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Urology , The First People&apos;s Hospital of Lianyungang , Lianyungang Clinical Medical College of Nanjing Medical University , Lianyungang , China ,</note>
								<orgName type="department" key="dep1">Department of Urology</orgName>
								<orgName type="department" key="dep2">Lianyungang Clinical Medical College</orgName>
								<orgName type="institution" key="instit1">The First People&apos;s Hospital of Lianyungang</orgName>
								<orgName type="institution" key="instit2">Nanjing Medical University</orgName>
								<address>
									<settlement>Lianyungang</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Chuanquan</forename><surname>Tu</surname></persName>
							<email>tuchuanquan1116@126.com</email>
							<idno type="ORCID">0000-0002-3344-1262</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Urology , The First People&apos;s Hospital of Lianyungang , Lianyungang Clinical Medical College of Nanjing Medical University , Lianyungang , China ,</note>
								<orgName type="department" key="dep1">Department of Urology</orgName>
								<orgName type="department" key="dep2">Lianyungang Clinical Medical College</orgName>
								<orgName type="institution" key="instit1">The First People&apos;s Hospital of Lianyungang</orgName>
								<orgName type="institution" key="instit2">Nanjing Medical University</orgName>
								<address>
									<settlement>Lianyungang</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">Shanghai Jiao Tong University , CHINA</note>
								<orgName type="institution">Shanghai Jiao Tong University</orgName>
								<address>
									<country key="CN">CHINA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_tAX5ZD3">The influence of LncRNA H19 polymorphic variants on susceptibility to cancer: A systematic review and updated meta-analysis of 28 case-control studies</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2021-07-26">July 26, 2021</date>
						</imprint>
					</monogr>
					<idno type="MD5">F139C0B7B87179747062D9D102F93864</idno>
					<idno type="DOI">10.1371/journal.pone.0254943</idno>
					<note type="submission">Received: April 5, 2021 Accepted: July 6, 2021</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T09:39+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_6rV3mY8">Objective</head><p xml:id="_W893AeS"><s xml:id="_ZE4sGjn">Although myriad researches upon the associations between LncRNA H19 polymorphic variants (rs2839698 G&gt;A, rs217727 G&gt;A, rs2107425 C&gt;T, rs2735971 A&gt;G and rs3024270 C&gt;G) and the susceptibility to cancer have been conducted, these results remained contradictory and perplexing.</s><s xml:id="_yed3TAw">Basing on that, a systematic review and updated meta-analysis was performed to anticipate a fairly precise assessment about such associations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_FSQCFbQ">Methods</head><p xml:id="_9ggaD4P"><s xml:id="_7SeqsNE">We retrieved the electronic databases EMBASE, PubMed and Web of Science for valuable academic studies before February 28, 2021.</s><s xml:id="_qZapxyk">Ultimately, 28 of which were encompassed after screening in this meta-analysis, and the available data was extracted and integrated.</s><s xml:id="_zrpn2jc">The pooled odds ratios (ORs) with 95% confidence intervals (CIs) was used to evaluate such associations.</s><s xml:id="_G4XmF2X">For multi-level investigation, subgroup analysis derived from source of controls together with genotypic method was preformed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yRjMnfV">Results</head><p xml:id="_XfNQ74C"><s xml:id="_5cExN2j">Eventually, 28 articles altogether embodying 57 studies were included in this meta-analysis.</s><s xml:id="_SAY7XTR">The results illuminated that LncRNA H19 polymorphisms mentioned above were all irrelevant to cancer susceptibility.</s><s xml:id="_8R5PB6A">Nevertheless, crucial results were found concentrated in population-based control group when subgroup analysis by source of controls were performed in H19 mutation rs2839698 and rs2735971.</s><s xml:id="_QwSH9Ks">Meanwhile, in the stratification analysis by genotypic method, apparent cancer risks were discovered by TaqMan method in H19 mutation rs2107425 and rs3024270.</s><s xml:id="_R98A3zg">Then, trial sequential analysis demonstrated that the results about such associations were firm evidence of effect.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_hGsE8Yd">Introduction</head><p xml:id="_BgVFtfa"><s xml:id="_B9Q6jXP">As a major public health problem in the world, cancer is the second biggest cause of death in the developed countries.</s><s xml:id="_hCw9Zaa">1,762,450 new cancer cases and 606,880 cancer mortalities are predicted to occur in the United States in 2019 <ref type="bibr" target="#b0">[1]</ref>.</s><s xml:id="_CazWb36">Nevertheless, the pathogeny of malignant tumor still remains vague.</s><s xml:id="_P2y3axY">Consensus amongst worldwide researchers is that both the environmental and genetic abnormality contribute to the carcinogenesis <ref type="bibr" target="#b1">[2]</ref>.</s><s xml:id="_Ydx9MP6">The aberration of genetic expression increases the risk of the initiation and progression of cancer <ref type="bibr" target="#b2">[3]</ref>.</s><s xml:id="_q7ZcMZa">Accumulating studies have been focusing on the repercussions of long non-uncoding RNA (lncRNA) mutation which has a place in the genetic factors mentioned above <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref>.</s></p><p xml:id="_fEseTxA"><s xml:id="_gxSwQYD">LncRNA H19 is 2.3 kb in length, located on chromosome 11p15.</s><s xml:id="_dEjWvPz"><ref type="bibr" target="#b4">5</ref> and lacking the open reading frames <ref type="bibr" target="#b7">[8]</ref>.</s><s xml:id="_p75XJT9">The H19 gene, which is maternal imprinted and expressed, plays an irreplaceable role during embryonic phase and decreases in postpartum mature tissues <ref type="bibr" target="#b8">[9]</ref>.</s><s xml:id="_nFzdT6g">As we know, LncRNA H19 is considered as a vital factor associated with, cancer susceptibility included, various biological process which impacts the invasion, metastasis, recurrence and poor prognosis of cancer <ref type="bibr" target="#b9">[10]</ref>.</s><s xml:id="_4eVGjac">It might extend the influence upon the development and progression of disease through the regulation of expression on and after transcription of the oncogene and antioncogene <ref type="bibr" target="#b10">[11]</ref>.</s><s xml:id="_bmP9k2u">An increasing number of studies have revealed that H19 gene upregulated in almost overall cancer, such as breast cancer, bladder cancer, colorectal cancer, gastric cancer, lung cancer, hepatocellular cnacer, ovarian cancer, pancreatic cancer and so on <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b11">12]</ref>.</s></p><p xml:id="_9TNaFdr"><s xml:id="_PznMNpz">Single nucleotide polymorphisms (SNPs), a type of genetic mutation, affect the gene expression and function, accordingly causing carcinogenesis <ref type="bibr" target="#b12">[13]</ref>.</s><s xml:id="_8YKj4BU">Previous studies have indicated the associations between the risks of cancer and several SNPs (rs2839698 G&gt;A, rs217727 G&gt;A, rs2107425 C&gt;T, rs2735971 A&gt;G and rs3024270 C&gt;G) <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref>.</s><s xml:id="_xCvu8Mf">For instance, Wang et al. conducted a study and found that H19 polymorphism rs217727 might influence the susceptibility to non-small cell lung cancer (NSCLC) <ref type="bibr" target="#b18">[19]</ref>.</s><s xml:id="_krxaJFe">However, another study conducted by <ref type="bibr">Lv et al.</ref> showed that H19 polymorphism rs217727 was not associated with overall cancer susceptibility <ref type="bibr" target="#b19">[20]</ref>.</s><s xml:id="_WYFM4tn">In that case, though considerable researches have been performed, pooled results seem to be conflicting.</s><s xml:id="_463yWz4">Herein, this meta-analysis aimed at deriving a more accurate evaluation in all relevant published studies of the associations between the H19 SNPs and overall cancer susceptibility.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_YhztQX5">Materials and methods</head><p xml:id="_5nzetDa"><s xml:id="_yqqDrWG">We conprehensively retrieved the electronic databases EMBASE, PubMed and Web of Science for all relevant articles published before February 28, 2021, utilizing terms including 'H19 gene', 'polymorphisms' or 'genetic mutation' with 'LncRNA' or 'H19 SNPs', and 'cancer susceptibility' or 'tumor'.</s><s xml:id="_g2e6xvD">Potential eligible studies were collected and integrated by manual work.</s><s xml:id="_szRM4s8">Additionally, we then removed the duplicate data from different articles.</s></p><p xml:id="_C7EqxWy"><s xml:id="_eJHMWvf">Meanwhile, the remaining articles were screened by following criteria: (1) Independent case-control or cohort studies; (2) Possessing at least one of H19 polymorphisms (rs2839698 G&gt;A, rs217727 G&gt;A, rs2107425 C&gt;T, rs2735971 A&gt;G and rs3024270 C&gt;G); (3) Availability of subgroup analysis statistical data of both cases and controls; (4) Enrolled patients with cancer diagnosed definitely by histopathological examination, and controls with no history of neoplasms.</s><s xml:id="_gMJbKyc">Correspondingly, the studies enrollment followed these exclusive criteria: (1) Without available data; (2) Without valuable results related to H19; (3) No case-control study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_d2GcK6n">Data extraction</head><p xml:id="_4puSdZc"><s xml:id="_SfN2ver">The available data from articles after screening were extracted and integrated respectively by two investigators (KP Wang and Z Zhu).</s><s xml:id="_Rm9E4Us">Upon the appearance of divergence, a third investigator (YQ Wang) would take intervention and help make a better decision.</s><s xml:id="_v9QXvH3">All extracted data were integrated in an united form, especially with regard to the following information: First author's name, Publication year, Ethnicity, Source of controls, Genotypic method, The number of cases and controls, The number of H19 polymorphisms carriers and non-carriers respectively as well as The results of the Hardy-Weinberg equilibrium (HWE) test.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Kucv94Q">Statistical analysis</head><p xml:id="_yNvesRe"><s xml:id="_5HZtUdt">In the meta-analysis, the pooled odds ratios (ORs) with 95% confidence intervals (CIs) were used to estimate the strength of the associations between the H19 polymorphisms and cancer susceptibility, applying five main genetic comparison models: allele model, homozygous model, heterozygous model, dominant model and recessive model.</s><s xml:id="_W5Zc3u2">According to Cochrane Q test and Higgins I <ref type="bibr" target="#b1">[2]</ref> statistic, the fixed and random effect model were adopted.</s><s xml:id="_PW6aqJE">I2 &lt; 50% suggested no obvious heterogeneity, in which case fixed effect model should be selected for calculation; only I2 ≧ 50% should the random effect model be selected.</s><s xml:id="_fd5sRAB">Generally, several factors, such as experimental scheme, sex, age, ethnicity, genotypic method and so on, could stimulate the heterogeneity.</s><s xml:id="_jMTDUPy">Therefore, subgroup analysis derived from source of controls and genotypic method was conducted, aiming at investigating the source of heterogeneity.</s><s xml:id="_X3YbbUt">The HWE test was adopted in the control groups to evaluate the gene and genotype frequency, and P value exceeded 0.05, guaranteeing a significant equilibrium.</s><s xml:id="_jfx8SwT">In addition, sensitive analysis was used to examine the stability and reliability of the results through recalculating the pooled ORs following the sequential exclusion of a single study at a time.</s><s xml:id="_kQDcUde">Meanwhile, we conducted Begg's funnel plots and Egger's linear regression test in order to verify the publication bias among these studies Statistical data was analyzed through Stata statistical software (Version 12.0, Stata Corporation, College Station, TX, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NCBGyuW">Trial sequential analysis</head><p xml:id="_cCfQMtM"><s xml:id="_vYZ3g7h">The results of the meta-analysis should relate the total number of randomized participants accounting for statistical diversity to avoid type I errors.</s><s xml:id="_78QufaY">Thus, trial sequential analysis (TSA) was performed to estimate the required information size, which maintained a 95% confidence interval, a 20% relative risk reduction, an overall type I error of 5% and a statistical test power of 80%.</s><s xml:id="_9fRZgHx">TSA could confirm greater statistical data reliability through modifying the threshold with dispersive data for significance level.</s><s xml:id="_SvfSrMt">We then calculated the required information size and constructed the trial sequential monitoring boundaries.</s><s xml:id="_NFnyfCk">If the blue line (representing the cumulative Z-curve) cross the sloping red line (representing the trial sequential monitoring boundary) or exceed the vertical red line (representing the required information size), a significant result would be reached, and further studies will be unnecessary.</s><s xml:id="_txqS5rQ">On the contrary, either the information size required not being reached or the cumulative Z-curve not crossing the boundary reveals that additional clinical trials were necessary to reach the sufficient information size for further verification.</s><s xml:id="_wzFRzPF">The TSA software (TSA, version 0.9, 2011; Copenhagen Trial Unit, Copenhagen, Denmark) was adopted in this study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_unVJQTu">Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_y4drWqd">Studies characteristics</head><p xml:id="_XHfRPyW"><s xml:id="_T7GWCVe">Primitively, a total of 262 articles were collected under the guidance of the retrieve strategy above for further screening.</s><s xml:id="_CCZbcmr">Then, 28 articles containing 57 studies met the inclusive criteria, ranging from Feburary 2008 to February 2020 as for publish date <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref>.</s><s xml:id="_Kf6DSys">The flow pathway was shown in Fig 1 <ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref><ref type="bibr" target="#b36">[37]</ref><ref type="bibr" target="#b37">[38]</ref><ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref><ref type="bibr" target="#b41">[42]</ref><ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref>.</s><s xml:id="_7dAHeed">Distribution of the genotypes in the controls was consistent in HWE.</s><s xml:id="_UNC93V2">The baseline characteristics of all the studies in this meta-analysis were extracted and tabulated in Table <ref type="table" target="#tab_2">1</ref>.</s><s xml:id="_XuYg7DE">These studies involved Asians, Caucasians, Africans and Mixed.</s><s xml:id="_WFbERDw">We separated these studies into two groups, including population-based group and hospital-based group, to help differentiate between various sources of control.</s><s xml:id="_z4FH2nE">Moreover, six genotypic methods altogether were performed in all these studies, such as Taqman, Illumina, PCR-RFLP, Sequenom and so on.</s></p><p xml:id="_AFerf5v"><s xml:id="_Hb3GwC7">Meanwhile, we calculated the pooled ORs and 95% CIs using five genetic model in order to evaluate the affinity between lncRNA H19 ploymorphisms and cancer susceptibility, results of which were tabulated in Table <ref type="table">2</ref>. Also, stratification analysis by source of controls and genotypic method was applied to explore the heterogeneity of all studies.</s><s xml:id="_TGZgQun">Table 1.</s><s xml:id="_bpXZwKK">Characteristics of individual studies included in the meta-analysis.</s><s xml:id="_NmWZrRA">First author Year Country/ Region Racial Source of controls Case Control Genotype distribution Genotyping methods Test for HWE Abbreviation case control χ 2 P 16 Studies for rs2839698 Poly morphism of the H19 Gene GG GA AA GG GA AA Li 2016 China Asian PB 1147 1203 583 462 102 666 462 75 TaqMan 0.582 0.446 CRC Hua 2016 China Asian HB 1049 1397 552 418 79 729 565 103 TaqMan 0.000 0.991 BC Gong 2016 China Asian HB 496 206 237 220 39 99 80 27 TaqMan 1.515 0.218 LC Yang 2015 China Asian HB 500 500 250 195 55 284 178 38 TaqMan 3.206 0.073 GC Verhaegh 2008 Netherlands Caucasian PB 177 204 54 74 49 52 109 43 PCR-RFLP 4.713 0.030 BC Yang 2018 China Asian HB 472 472 215 211 40 245 185 32 KASP 1.372 0.241 HCC Guo 2017 China Asian HB 362 741 133 171 58 244 377 120 Illumina 0.060 0.806 OSCC He 2017 China Asian HB 193 383 83 98 12 178 175 30 TaqMan 5.876 0.015 Osteosarcoma Cui 2018 China Asian HB 1491 1677 801 568 122 875 673 129 TaqMan 2.238 0.135 BCa Mohammad 2019 Iran Asian HB 111 130 15 57 39 53 55 22 4P-ARMSPCR 0.665 0.415 BCa Wu 2019 China Asian HB 359 1190 140 178 41 532 524 134 TaqMan 1.927 0.165 HCC Yang 2019 China Asian HB 431 431 206 170 55 192 184 55 PCR 4.376 0.036 BC Wang 2019 China Asian HB 563 1532 277 225 61 712 645 175 TaqMan 2.217 0.136 LC Lin 2017 China Asian HB 1005 1020 452 440 113 484 432 104 PCR 0.144 0.705 BCa Yu 2020 China Asian HB 315 441 134 140 40 154 211 74 PCR 0.132 0.716 CRC Zhang 2020 China Asian HB 201 196 70 93 38 92 88 16 Sequenom MassARRAY 0.514 0.473 OC 17 Studies for rs217727 G Poly morphism of the H19 Gene GG GA AA GG GA AA Hua 2016 China Asian HB 1046 1394 431 467 148 573 665 156 TaqMan 1.397 0.237 BC Li 2016 China Asian PB 1147 1203 480 514 153 456 570 177 TaqMan 0.686 0.407 CRC Xia 2016 China Asian PB 464 467 160 156 148 139 212 116 CRS-RFLP 0.490 0.000 BCa Yang 2015 China Asian HB 500 500 160 252 88 193 244 63 TaqMan 0.431 0.512 GC Verhaegh 2008 Netherlands Caucasian PB 177 204 114 59 4 115 80 9 PCR-RFLP 1.314 0.252 BC Yin 2018 China Asian PB 556 395 204 264 88 165 172 58 Illumina 0.028 0.866 LC Guo 2017 China Asian HB 362 740 101 181 80 255 348 137 Illumina 0.004 0.949 OSCC He 2017 China Asian HB 193 383 79 102 12 195 165 23 TaqMan 7.862 0.005 Osteosarcoma Abdollahzadeh 2018 Iran Asian HB 150 100 116 29 5 86 14 0 PCR-RFLP 3.167 0.075 BCa Cui 2018 China Asian HB 1488 1675 611 692 185 685 773 217 TaqMan 0.257 0.612 BCa Hu 2017 China Asian HB 416 416 133 200 83 128 196 92 TaqMan 0.247 0.619 PC Mohammad 2019 Iran Asian HB 111 130 79 30 2 64 54 12 4P-ARMSPCR 0.195 0.659 BCa Wu 2019 China Asian HB 359 1190 154 170 35 495 539 156 TaqMan 1.470 0.225 HCC Yang 2019 China Asian HB 431 431 185 202 44 191 188 52 PCR 1.065 0.302 BC Wang 2019 China Asian HB 564 1535 162 277 125 493 751 291 TaqMan 0.103 0.749 LC Li 2019 China Asian HB 200 200 51 140 9 84 90 26 TaqMan 43.168 0.000 BC Lin 2017 China Asian HB 1005 1020 403 471 131 465 450 105 PCR 0.131 0.718 BCa Li 2018 China Asian HB 555 618 210 250 95 246 305 97 TaqMan 1.911 0.167 LC 10 Studies for rs2107425 Poly morphism of the H19 Gene CC CT TT CC CT TT Verhaegh 2008 Netherlands Caucasian PB 177 204 92 65 20 89 96 19 PCR-RFLP 2.545 0.111 BC Song 2009 Mixed Caucasian PB 5366 8538 2619 2192 555 4029 3667 842 TaqMan, Sequenom MassArray 9.082 0.003 OC Quaye 2009 Mixed Caucasian PB 1460 2463 767 544 149 1118 1098 247 TaqMan 12.392 0.000 OC (Continued ) CI: 1.04-1.91;</s><s xml:id="_nTTrrRp">recessive model: OR = 1.46, 95% CI: 1.13-1.89)</s><s xml:id="_mAxWgdQ">was observed in the stratification analysis by source of control.</s><s xml:id="_ytjSSDd">In addition, no significant results were detected in the subgroup analysis by genotypic method.</s><s xml:id="_fS2Ywv9">rs217727 G&gt;A and cancer susceptibility In this meta-analysis, 17 Studies focusing on rs217727 G&gt;A polymorphism and cancer susceptibility included 8678 cases and 11,207 controls.</s><s xml:id="_JwuEGfk">No significant association was indicated through the pooled risk estimation under allele model (OR = 1.04, 95% CI = 0.96-1.13),</s><s xml:id="_7DjwfTS">dominant model (OR = 1.07, 95% CI = 0.95-1.21),</s><s xml:id="_CFks7ha">heterozygous model (OR = 1.07, 95% CI = 0.94-1.21),</s><s xml:id="_MeuqX8y">homozygous model (OR = 1.06, 95% CI = 0.90-1.24)</s><s xml:id="_3hfhEGY">and recessive model (OR = 1.06, 95% CI = 0.79-1.42)</s><s xml:id="_XeahSzv">(Fig 3).</s><s xml:id="_aJFgUDA">While no significant results were observed in subgroup analysis Studies for rs2735971 Poly morphism of the H19 Gene AA AG GG AA AG GG Hua 2016 China Asian HB 1049 1396 43 302 704 46 422 928 TaqMan 2.128 0.145 BC Li 2016 China Asian PB 1147 1203 773 334 40 765 398 40 TaqMan 0.278 0.598 CRC Yang 2018 China Asian HB 472 472 12 126 327 13 139 313 KASP 0.001 0.974 HCC Guo 2017 China Asian HB 461 739 129 141 191 80 308 351 Illumina 65.528 0.000 OSCC He 2017 China Asian HB 193 383 11 94 88 32 182 169 TaqMan 4.848 0.028 Osteosarcoma Li 2019 China Asian HB 200 200 10 62 128 4 70 126 TaqMan 0.479 0.489 BC 8 Studies for rs3024270 Poly morphism of the H19 Gene CC GC GG CC GC GG Hua 2016 China Asian HB 1047 1395 174 527 346 260 688 447 TaqMan 1.254 0.263 BC Li 2016 China Asian PB 1147 1203 385 527 235 420 582 201 TaqMan 4.860 0.027 CRC Yang 2018 China Asian HB 472 472 95 225 151 81 215 170 KASP 0.449 0.503 HCC Guo 2017 China Asian HB 362 740 75 183 104 145 350 245 Illumina 0.112 0.738 OSCC He 2017 China Asian HB 193 383 17 91 85 31 179 173 TaqMan 1.134 0.287 OSC Wu 2019 China Asian HB 359 1190 87 187 85 334 593 263 TaqMan 0.628 0.428 HCC Yang 2019 China Asian HB 431 431 114 210 107 120 208 103 PCR 0.275 0.600 BC Li 2019 China Asian HB 200 200 16 101 83 22 97 81 TaqMan 3.791 0.052 BC Abbreviation: SOC: source of control; HB: hospital-based; HWE: Hardy-Weinberg equilibrium; BC: Bladder cancer; BCa: Breast cancer; LC: Lung cancer; HCC: Hepatocellular cancer; OSCC: Oral squamous cell carcinoma; OSC:Osteosarcoma; PC: Pancreatic cancer; CRC: Colorectal cancer; GC: Gastric cancer; OC: Ovarian cancer.</s><s xml:id="_dSwkq5w"><ref type="url" target="https://doi.org/10.1371/journal.pone.0254943.t001">https://doi.org/10.1371/journal.pone.0254943.t001</ref></s><s xml:id="_kyJ2jEY">Table 2. Meta-analysis results for the included studies of the association between LncRNA H19 polymorphisms and risk of cancer.</s><s xml:id="_k87dvCf">Variables No. of studies Allele model Dominant model Heterozygous model Homozygous model Recessive model OR (95% CI) P values I-squared (%) OR (95% CI) P values I-squared (%) OR (95% CI) P values I-squared (%) OR (95% CI) P values I-squared (%) OR (95% CI) P values I-squared (%) 1. rs2839698 G&gt;A A vs G (GA+AA) vs GG GA vs GG AA vs GG AA vs (GA+GG) All 16 1.08(0.99,1.19)</s><s xml:id="_r58PaNt">&lt;0.001 75.3 1.08 (0.96,1.21) &lt;0.001 71.7 1.06 (0.95,1.17) 0.001 63.3 1.16 (0.92,1.42) &lt;0.001 71.7 1.13 (0.97,1.31) 0.002 58.1 Source of control PB 2 1.17 (1.04,1.31)</s><s xml:id="_XWYUGH9">0.347 &lt;0.1 1.02 (0.68,1.54) 0.076 68.2 0.91 (0.53,1.55) 0.032 78.2 1.41 (1.04,1.91)</s><s xml:id="_RAU8QUt">0.290 10.9 1.46 (1.13,1.89)</s><s xml:id="_ahu2RMr">0.934 &lt;0.1 HB 14 1.08 (0.97,1.19) &lt;0.001 76.9 1.09 (0.96,1.24) &lt;0.001 73.2 1.07 (0.95,1.20) 0.001 64.0 1.14 (0.92,1.42) &lt;0.001 73.1 1.08 (0.92,1.28) 0.004 57.9 Method of genotype TaqMan 8 1.05 (0.96,1.14) 0.024 56.5 1.07 (0.96,1.18) 0.052 49.9 1.06 (0.96,1.17) 0.108 40.6 1.08 (0.89,1.32) 0.038 52.9 1.05 (0.88,1.26) 0.056 49.0 non-TaqMan 8 1.15 (0.95,1.39) &lt;0.001 84.2 1.12 (0.87,1.45) &lt;0.001 82.1 1.05 (0.84,1.33) &lt;0.001 75.9 1.34 (0.91,1.96) &lt;0.001 81.5 1.29 (0.95,1.76) 0.053 57.1 2. rs217727 G&gt;A A vs G (GA+AA) vs GG GA vs GG AA vs GG AA vs (GA+GG) All 17 1.04 (0.96,1.13) &lt;0.001 69.9 1.07 (0.95,1.21) &lt;0.001 72.4 1.07 (0.94,1.21) &lt;0.001 71.9 1.06 (0.90,1.24) 0.001 59.2 1.03 (0.89,1.19) 0.001 59.7 Source of control PB 4 0.97 (0.83,1.13) 0.051 61.4 0.90 (0.72,1.11) 0.048 62.1 0.85 (0.66,1.11) 0.014 71.6 0.97 (0.75,1.26) 0.154 42.9 1.06 (0.79,1.42) 0.056 60.4 HB 13 1.07 (0.97,1.18) &lt;0.001 70.4 1.14 (0.99,1.30) &lt;0.001 70.1 1.15 (1.00,1.31)</s><s xml:id="_vxGXGbA">0.001 63.3 1.09 (0.90,1.31) 0.002 62.2 1.01 (0.85,1.20) 0.001 62.7 Method of genotype TaqMan 9 1.04 (0.95,1.14) 0.009 60.8 1.11 (0.96,1.28) 0.001 70.4 1.12 (0.96,1.31) &lt;0.001 71.7 1.02 (0.84,1.22) 0.015 57.8 0.97 (0.81,1.17) 0.006 62.6 non-TaqMan 8 1.02 (0.86,1.21) &lt;0.001 76.9 1.01 (0.80,1.26) &lt;0.001 77.0 0.98 (0.77,1.24) &lt;0.001 75.5 1.11 (0.84,1.47) 0.018 58.8 1.12 (0.88,1.41) 0.044 51.6 3. rs2107425 C&gt;T T vs C (CT+TT) vs CC CT vs CC TT vs CC TT vs (CT+CC) All 10 0.96 (0.89,1.04) 0.001 68.5 0.95 (0.85,1.06) &lt;0.001 71.5 0.95 (0.84,1.07) &lt;0.001 71.6 0.97 (0.83,1.13) 0.010 58.6 0.98 (0.87,1.12) 0.035 50.1 Source of control PB 7 0.96 (0.88,1.06) &lt;0.001 75.8 0.92 (0.80,1.06) &lt;0.001 77.8 0.90 (0.78,1.03) &lt;0.001 75.5 1.01 (0.85,1.19) 0.016 61.5 1.04 (0.93,1.17) 0.190 31.2</s><s xml:id="_8YH2UTB">HB 3 0.96 (0.82,1.13) 0.154 46.6 1.04 (0.88,1.23) 0.360 2.1 1.12 (0.94,1.32) 0.602 &lt;0.1 0.85 (0.59,1.22) 0.114 54.0 0.79 (0.58,1.09) 0.150 47.3 Method of genotype TaqMan 3 0.86(0.80,0.94)</s><s xml:id="_enMF2KN">0.396 &lt;0.1 0.86 (0.71,1.05) 0.098 57.0 0.90 (0.68,1.21) 0.013 76.9 0.81 (0.62,1.04) 0.206 36.7 0.84 (0.59,1.20) 0.038 69.3 non-TaqMan 7 1.00 (0.91,1.10) 0.004 68.9 0.99 (0.86,1.13) 0.002 70.6 0.97 (0.85,1.11) 0.006 66.9 1.04 (0.87,1.24) 0.028 57.6 1.05 (0.96,1.15) 0.124 42.2 4. rs2735971 A&gt;G G vs A (AG+GG) vs AA AG vs AA GG vs AA GG vs (AG+AA) All 6 0.91 (0.75,1.11) &lt;0.001 81.9 0.72 (0.44,1.17) &lt;0.001 86.8 0.68 (0.41,1.13) &lt;0.001 86.3 0.76 (0.45,1.29) &lt;0.001 81.5 0.99 (0.89,1.11) 0.247 26.2 Source of control PB 1 0.89 (0.77,1.03) --0.85 (0.71,1.00) --0.83 (0.70,0.99) --0.99 (0.63,1.55) --1.05 (0.67,1.64) --HB 5 0.92 (0.72,1.19) &lt;0.001 85.5 0.69 (0.35,1.34) &lt;0.001 85.0 0.65 (0.33,1.29) &lt;0.001 84.4 0.71 (0.38,1.34) &lt;0.001 82.1 0.99 (0.88,1.11) 0.247 26.2 Method of genotype TaqMan 4 0.96 (0.87,1.05) 0.503 &lt;0.1 0.86 (0.66,1.12) 0.229 30.6 0.84 (0.63,1.12) 0.205 34.5 0.92 (0.66,1.30) 0.257 25.8 1.04 (0.91,1.19) 0.999 &lt;0.1 non-TaqMan 2 0.82 (0.45,1.50) &lt;0.001 93.9 0.55 (0.16,1.86) 0.004 87.8 0.50 (0.15,1.67) 0.006 86.6 0.58 (0.18,1.90) 0.006 86.7 0.92 (0.77,1.10) 0.037 76.9 5. rs3024270 C&gt;G G vs C (CG+GG) vs CC CG vs CC GG vs CC GG vs (CG+CC) All 8 1.03 (0.98,1.10) 0.237 24.1 1.07 (0.97,1.18) 0.630 &lt;0.1 1.05 (0.95,1.17) 0.811 &lt;0.1 1.09 (0.97,1.23) 0.218 21.4 1.03 (0.94,1.13) 0.177 31.5 Source of control PB 1 1.11 (0.99,1.25) --1.06 (0.90,1.26) --0.99 (0.82,1.18) --1.28 (1.01,1.61)</s><s xml:id="_HBdpZr9">--1.28 (1.04,1.58)</s><s xml:id="_748ywzF">--HB 7 1.01 (0.95,1.08) 0.293 17.9 1.07 (0.95,1.20) 0.513 &lt;0.1 1.09 (0.96,1.23) 0.809 &lt;0.1 1.04 (0.90,1.19) 0.297 17.5 0.98 (0.88,1.08) 0.563 &lt;0.1 Method of genotype TaqMan 5 1.08 (1.01,1.16)</s><s xml:id="_A7hsgY4">0.873 &lt;0.1 1.12 (1.00,1.26)</s><s xml:id="_W3KEXEh">0.788 &lt;0.1 1.08 (0.96,1.22) 0.622 &lt;0.1 1.21 (1.05,1.39)</s><s xml:id="_xAvkPdU">0.851 &lt;0.1 1.10 (0.99,1.23) 0.534 &lt;0.1 non-TaqMan 3 0.93 (0.84,1.03) 0.309 14.9 0.95 (0.79,1.14) 0.532 &lt;0.1 0.99 (0.82,1.20) 0.763 &lt;0.1 0.88 (0.71,1.08) 0.353 4.1 0.88 (0.74,1.03) 0.404 &lt;0.1 <ref type="url" target="https://doi.org/10.1371/journal.pone.0254943.t002">https://doi.org/10.1371/journal.pone.0254943.t002</ref></s><s xml:id="_uUJku83">by genotypic method, positive results were found in hospital-based controls (heterozygous model: OR = 1.15, 95% CI: 1.00-1.31).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_bU6xbxc">rs2839698 G&gt;A and cancer susceptibility</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4mkFGx9">rs2107425 C&gt;T and cancer susceptibility</head><p xml:id="_z6B2vev"><s xml:id="_d2KXZds">A total of 10 studies embodying 11,468 cases and 16,555 controls were investigated to LncRNA H19 polymorphic variants rs2107425 C&gt;T and the susceptibility to cancer.</s><s xml:id="_g2d2wYH">Analogously, no significant association between rs2107425 C&gt;T polymorphism and cancer risk was shown in the meta-analysis according to the pooled ORs of these studies under allele model (OR = 0.96, 95% CI = 0.89-1.04),</s><s xml:id="_ZU6Ug37">dominant model (OR = 0.95, 95% CI = 0.85-1.06),</s><s xml:id="_32RG6WZ">heterozygous model (OR = 0.95, 95% CI = 0.84-1.07),</s><s xml:id="_EJE9FNr">homozygous model (OR = 0.97, 95% CI = 0.83-1.13)</s><s xml:id="_933FKkc">and recessive model (OR = 0.98, 95% CI = 0.87-1.12)</s><s xml:id="_6wcvYSa">(Fig <ref type="figure">4</ref>).</s><s xml:id="_DFkER5Y">Nevertheless, as to the stratification analysis of genotypic method, the result was significant only in TaqMan (allele model: OR = 0.86, 95% CI = 0.80-0.94),</s><s xml:id="_gyMkuF5">while no significant results was detected in subgroup of source of control.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_jWnYbY6">rs2735971 A&gt;G and cancer susceptibility</head><p xml:id="_BYvtkke"><s xml:id="_4wN7sea">The present meta-analysis enrolled 3,522 cases and 4,393 controls from a sum of six studies on rs2735971 A&gt;G polymorphism and cancer susceptibility.</s><s xml:id="_eVvSDDd">No significant association was observed among these studies under all the genetic models (allele model (OR = 0.91, 95% CI = 0.75-1.11),</s><s xml:id="_edX292H">dominant model (OR = 0.72, 95% CI = 0.44-1.17),</s><s xml:id="_sbWrtNz">heterozygous model (OR = 0.68, 95% CI = 0.41-1.13),</s><s xml:id="_BETNTbe">homozygous model (OR = 0.76, 95% CI = 0.45-1.29)</s><s xml:id="_x2eJD9G">and recessive model (OR = 0.99, 95% CI = 0.89-1.11))</s><s xml:id="_25TNuQ8">(Fig 5).</s><s xml:id="_7XjTZKS">Additionally, the results of stratified analysis by genotypic method were not positive.</s><s xml:id="_TdevCuD">By contrast, in subgroup analysis by source of control, feebly positive results were shown in population-based controls(dominant model: OR = 0.85, 95% CI = 0.71-1.00;</s><s xml:id="_dXfC8C2">heterozygous model: OR = 083, 95% CI = 0.70-0.99).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QE4aTbG">rs3024270 C&gt;G and cancer susceptibility</head><p xml:id="_zBw2PFa"><s xml:id="_8aNbpDU">No significant association existed between rs3024270 mutation and cancer susceptibility as shown by the pooled risks of 8 relevant studies consisting 4,211 cases and 6,014 controls under allele model (OR = 1.03, 95% CI = 0.98-1.10),</s><s xml:id="_dc7ydXw">dominant model(OR = 1.07, 95% CI = 0.97-1.18),</s><s xml:id="_jqXzQaZ">heterozygous model(OR = 1.05, 95% CI = 0.95-1.17),</s><s xml:id="_bnwHQ4g">homozygous model (OR = 1.09, 95% CI = 0.97-1.23)</s><s xml:id="_tV7YUGW">and recessive model(OR = 1.03, 95% CI = 0.94-1.13)</s><s xml:id="_35SjjXz">(Fig <ref type="figure" target="#fig_4">6</ref>).</s><s xml:id="_qXkR97J">However, stratification analysis by source of control indicated significant association with cancer susceptibility in the population-based control group (homozygous model: OR = 1.28, 95% CI = 1.01-1.61).</s><s xml:id="_Q4yg2sp">Furthermore, the results of analysis stratified by genotypic method were more significant while using Taq-Man than non-TaqMan methods (allele model: OR = 1.08, 95% CI = 1.01-1.16,</s><s xml:id="_TQGqVE7">dominant model: OR = 1.12, 95% CI = 1.00-1.26</s><s xml:id="_QDe75sw">and homozygous model: OR = 1.21, 95% CI = 1.05-1.39).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VAk4CmB">Discussion</head><p xml:id="_MTy4822"><s xml:id="_dup4Jcx">An increasing number of studies have been focusing on the mutation of H19 when it comes to the genesis and development of various cancer <ref type="bibr" target="#b44">[45]</ref>.</s><s xml:id="_EJ4mPEx">As a long non-coding RNA, H19 lacks the open reading frame to translate protein whose end product is RNA sequence and can participate in downstream RNA regulatory <ref type="bibr" target="#b20">[21,</ref><ref type="bibr" target="#b45">46]</ref>.</s><s xml:id="_SHAnvpw">LncRNA H19 is an imprinted gene the aberrant expression of which is associated with cancer susceptibility <ref type="bibr" target="#b21">[22]</ref>.</s><s xml:id="_fevPWsU">In this meta-analysis, SNPs (rs2839698 G&gt;A, rs217727 G&gt;A, rs2107425 C&gt;T, rs2735971 A&gt;G and rs3024270 C&gt;G) were included to investigate the relationship between these polymorphisms and the risk of cancer.</s></p><p xml:id="_gKUvr6a"><s xml:id="_g5P6NNU">Previously, several meta-analysis on aberration of H19 have been conducted thanks to the identification of numerous LncRNAs <ref type="bibr" target="#b22">[23,</ref><ref type="bibr" target="#b23">24]</ref>.</s><s xml:id="_DY54j2V">Though the results were contrary to many studies, a meta-analysis performed by Lv. revealed that rs217727 were uncorrelated to overall cancer risk <ref type="bibr" target="#b19">[20]</ref>.</s><s xml:id="_uheQDsP">It might account for the lack of the interactive microRNAs (miRNAs) which could influence the regulation and modification of lncRNAs SNPs directly <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b46">47]</ref>.</s><s xml:id="_Yygnm6P">In that case, the position where gene structural changes caused by the polymorphism might differ from where the gene binds with elements such as miRNAs that regulate lncRNA expression, thus indicating no significant association with overall cancer risk.</s><s xml:id="_DurD7zP">Also, another meta-analysis conducted by Li et al. inspired us on the possible reason <ref type="bibr" target="#b47">[48]</ref>.</s><s xml:id="_Ces89tB">The various cancer location and patient ethnicity might accounting for the discrepancies among the studies examined.</s><s xml:id="_PdPWayg">In these studies, a small sample size and controversial results caused by the former factor might make these analysis relatively unreliable.</s><s xml:id="_B4bhFvq">Herein, we conducted this meta-analysis with the largest sample capacity and the most up-to-date studies and data, comprehensively analyzing all literatures to study such association.</s><s xml:id="_ThDWXc2">According to quantitative synthesis results, all the mutation mentioned above were found no significant association.</s></p><p xml:id="_HrVMpSr"><s xml:id="_GTttHrv">When stratified by source of control, significant association was found in the populationbased control group between rs2839698, rs2735971 and rs3024270 polymorphisms and the susceptibility to cancer, whereas significant results in hospital-based control group were only found in SNP rs217727.</s><s xml:id="_hTPexYK">Lack of the representativeness might account for the phenomena.</s><s xml:id="_3VutU8t">Moreover, in the subgroup analysis by genotypic method, significant results were also found between the risk of cancer and rs2107425, rs3024270 polymorphisms adopting TaqMan method for genotyping, whereas similar results were not found while using other genotypic methods.</s><s xml:id="_UQsxh97">The possible reason might be that different genotypic methods lead to different statistical results owing to their relative merits.</s><s xml:id="_QPGkJhp">The merits of TaqMan are the lower probability of PCR pollution due to that the reaction happens in the PCR process, avoiding separation and elution process <ref type="bibr" target="#b48">[49]</ref>.</s></p><p xml:id="_bK5QTrA"><s xml:id="_Qn8xQUP">TSA, as an statistical tool, is similar to interim analysis in a single trial, where trial monitoring boundaries are drawn for each outcome whether to continue additional trials to assess for evidence while a P value is small enough to show the projected effect or for futility <ref type="bibr" target="#b49">[50]</ref>.</s><s xml:id="_wm4XW8u">The association shown in the results of this meta-analysis could be unreliable accounting for limited data.</s><s xml:id="_XR727v9">Therefore, TSA was adopted in order to diminish the probability of type I error and verify whether the evidence of our results was adequate or not.</s><s xml:id="_fPZjqp4">The results about the associations between LncRNA H19 polymorphic variants (rs2839698, rs217727, rs2107425, rs2735971 and rs3024270) and the susceptibility to cancer were firm evidence of effect <ref type="bibr" target="#b50">[51]</ref>.</s><s xml:id="_6QzmpU6">Thus lager sample size for further verification is unnecessary.</s></p><p xml:id="_cHWM7uE"><s xml:id="_GPgZaD4">Inevitably, several additional limitations should be warranted in this meta-analysis.</s><s xml:id="_sXGGZUf">(1).</s><s xml:id="_szXnHuv">As a multifactorial disease, overall cancers are influenced by genetic combined with environmental factors.</s><s xml:id="_AgJpFvZ">Focusing on single gene region, this meta-analysis ignored the complex interaction between various factors, in which case the association was unilateral; <ref type="bibr" target="#b1">(2)</ref>.</s><s xml:id="_HPCFM3B">The amount of studies in the subgroup analysis was relatively small.</s><s xml:id="_zttbmCz">Subgroups with less than three studies were retained, thus might causing the potential false associations; (3).</s><s xml:id="_xqKVwmE">With the limit of the study amount, subgroup analysis based on race or cancer subtypes was not performed in this article.</s><s xml:id="_VkX4NRY">Additionally, subgroup analysis based on sex, age and gene dosage failed to be conducted accounting for the unavailability of relevant detailed data <ref type="bibr" target="#b51">[52]</ref>.</s><s xml:id="_bNnRMQP">Besides, we failed to acquire the information of details such as age and gender distribution, amount of multiple gene mutation cases and so on, in which case, multi-trait analysis seems unable to implement <ref type="bibr" target="#b52">[53]</ref>.</s><s xml:id="_uxc5nTj">(4).</s><s xml:id="_5eMGtBV">Quality control is also one of the limitations of our study.</s><s xml:id="_rdQu9uC">As most of the meta-analysis, the individual study quality determines overall quality.</s><s xml:id="_ajkcQ24">The test of Hardy-Weinberg equilibrium was conducted in this study, results of which indicates that genotype and allele frequencies remain unchanged over the generations.</s><s xml:id="_wMe37YF">Nevertheless, specific quality test could be performed <ref type="bibr" target="#b53">[54]</ref>.</s><s xml:id="_nDTsRHq"><ref type="bibr" target="#b4">(5)</ref>.</s><s xml:id="_4AhFVVD">Causal inference analysis could be another limitation.</s><s xml:id="_czr597k">Gene mutation can affect the occurrence and development of cancer by affecting intermediate phenotype or other exposure factors.</s><s xml:id="_sgSgTPf">Previous study has shown that SNPs could be of much importance in modulating some novel biomarkers.</s><s xml:id="_AersEAK">Mendelian randomization study plays a vital role in discovering the causation of various cancers <ref type="bibr" target="#b54">[55]</ref><ref type="bibr" target="#b55">[56]</ref><ref type="bibr" target="#b56">[57]</ref>.</s><s xml:id="_MheC4HH">Conditions needs to be met for this study, while we failed to find the intermediate phenotype or other exposure factors in H19 mutation cases.</s></p><p xml:id="_T8kKKuX"><s xml:id="_nawXRUr">Genetic variability is significant when it comes to evaluation of disease susceptibility.</s><s xml:id="_4ZyWGR7">In study by Allemailem at al., SNPs was helpful not only in diagnosis of prostate, but also in the further treatment for individuals <ref type="bibr" target="#b57">[58]</ref>.</s><s xml:id="_38FecHG">Meanwhile, contributions have been made in plenty of studies retrieved in our article to testified the possibility of H19 SNPs in diagnosis and individualized treatment of various cancer.</s><s xml:id="_BTRJGDT">In this meta-analysis, we concentrated on the association between the overall cancer susceptibility and H19 mutation.</s><s xml:id="_f4cZtx5">Insufficient data of gene dosage and tumor staging from raw studies adds complications to establishing a prediction model <ref type="bibr" target="#b58">[59,</ref><ref type="bibr" target="#b59">60]</ref>.</s></p><p xml:id="_DV8uMRV"><s xml:id="_actMHDH">Consensus has been reached that H19 is involved in various biological process, but the potential mechanisms remain unknown.</s><s xml:id="_rENgDEW">The study by Zheng at al. revealed that gene mutation can promote self adaptation <ref type="bibr" target="#b60">[61]</ref>.</s><s xml:id="_P52twjY">On the other hand, current researches have focused on the N4-acetylcytidine on RNA, which can impact the development of cancer <ref type="bibr" target="#b61">[62]</ref>.</s><s xml:id="_NYYz3ND">Thus, further exploration of according mechanism is necessary.</s><s xml:id="_edWDZt8">Hence, to guaranty reliability of our metaanalysis, more large-sample, multi-center and high-quality researches should focus on the influence of different factors in the subsequent studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_CARzBec">Conclusion</head><p xml:id="_G7cDPpr"><s xml:id="_UmRXW6x">To conclude, the results of this meta-analysis revealed that five H19 polymorphisms (rs2839698 G&gt;A, rs217727 G&gt;A, rs2107425 C&gt;T, rs2735971 A&gt;G and rs3024270 C&gt;G) had no significant association with the overall cancer susceptibility, thereby suggesting that H19 might be not qualified for the ideal marker in the diagnosis and treatment of cancer.</s><s xml:id="_BQndnAZ">However, after the stratification analysis, inconsistent results still existed in different genotypic method and source of control.</s><s xml:id="_khZxjZA">Thus, more high-quality studies on cancer patients of different factors were needed to confirm these findings.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 .</head><label>1</label><figDesc><div><p xml:id="_X3zUCu3"><s xml:id="_7VtGzXV">Fig 1.</s><s xml:id="_vv9ngaj">The flowchart of literature search and selection procedure.</s><s xml:id="_xEjruM9">https://doi.org/10.1371/journal.pone.0254943.g001</s></p></div></figDesc><graphic coords="4,200.01,488.13,288.00,195.08" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 2 .</head><label>2</label><figDesc><div><p xml:id="_8zX3CDf"><s xml:id="_ZThPTRd">Fig 2. Forest plot of the association between H19 polymorphism rs2839698 G&gt;A and cancer susceptibility.</s><s xml:id="_ju6hSas">A: allele model; B: dominant model; C: heterozygote model; D: homozygote model; E: recessive model.</s><s xml:id="_2K9KX4r">https://doi.org/10.1371/journal.pone.0254943.g002</s></p></div></figDesc><graphic coords="8,43.20,78.01,532.80,333.35" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 3 .</head><label>3</label><figDesc><div><p xml:id="_BTaJNWy"><s xml:id="_9mY89VN">Fig 3. Forest plot of the association between H19 polymorphism rs217727 G&gt;A and cancer susceptibility.</s><s xml:id="_rCBX4BW">A: allele model; B: dominant model; C: heterozygote model; D: homozygote model; E: recessive model.</s><s xml:id="_y8C7UgA">https://doi.org/10.1371/journal.pone.0254943.g003</s></p></div></figDesc><graphic coords="9,43.20,78.01,532.80,333.35" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 5 .</head><label>5</label><figDesc><div><p xml:id="_6Bhm3JU"><s xml:id="_gEX4nnb">Fig 5. Forest plot of the association between H19 polymorphism rs2735971 A&gt;G and cancer susceptibility.</s><s xml:id="_ERsPdj9">A: allele model; B: dominant model; C: heterozygote model; D: homozygote model; E: recessive model.</s><s xml:id="_wg2yukw">https://doi.org/10.1371/journal.pone.0254943.g005</s></p></div></figDesc><graphic coords="11,43.20,78.01,532.80,308.13" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig 6 .</head><label>6</label><figDesc><div><p xml:id="_eWk4N5S"><s xml:id="_m2RyJmA">Fig 6.</s><s xml:id="_s7qwChT">Forest plot of the association between H19 polymorphism rs3024270 C&gt;G and cancer susceptibility.</s><s xml:id="_pdZBfw9">A: allele model; B: dominant model; C: heterozygote model; D: homozygote model; E: recessive model.</s><s xml:id="_5qqJRUc">https://doi.org/10.1371/journal.pone.0254943.g006</s></p></div></figDesc><graphic coords="12,43.20,78.01,532.80,308.35" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig 7 .</head><label>7</label><figDesc><div><p xml:id="_2WEsv56"><s xml:id="_9CKuvdc">Fig 7. Sensitivity analysis under the allele model.</s><s xml:id="_kdKVXve">A: rs2839698; B: rs217727; C: rs2107425; D: rs2735971; E: rs3024270.</s><s xml:id="_cG8Qw7e">https://doi.org/10.1371/journal.pone.0254943.g007</s></p></div></figDesc><graphic coords="13,43.20,78.01,532.80,303.31" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig 8 .</head><label>8</label><figDesc><div><p xml:id="_PXVQaHw"><s xml:id="_dTjJS3V">Fig 8. Begg's funnel plot of publication bias test in the allele model.</s><s xml:id="_5etCqk6">A: rs2839698; B: rs217727; C: rs2107425; D: rs2735971; E: rs3024270.</s><s xml:id="_Pm2QRTb">https://doi.org/10.1371/journal.pone.0254943.g008</s></p></div></figDesc><graphic coords="14,43.20,78.01,532.80,308.13" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="15,43.20,78.01,532.80,288.68" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_hMVyPZq"><s xml:id="_Azg9sUG">(Continued)</s></p></div></figDesc><table><row><cell cols="3">First author Year Country/</cell><cell>Racial</cell><cell>Source of</cell><cell cols="2">Case Control</cell><cell cols="3">Genotype distribution</cell><cell></cell><cell>Genotyping</cell><cell cols="2">Test for</cell><cell>Abbreviation</cell></row><row><cell></cell><cell></cell><cell>Region</cell><cell></cell><cell>controls</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>methods</cell><cell>HWE</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>case</cell><cell></cell><cell>control</cell><cell></cell><cell></cell><cell>χ 2</cell><cell>P</cell></row><row><cell>Barnholtz-</cell><cell>2014</cell><cell>USA</cell><cell>Caucasian</cell><cell>PB</cell><cell>1225</cell><cell>1118</cell><cell cols="4">604 516 105 521 478 119</cell><cell>Illumina</cell><cell cols="2">0.124 0.725</cell><cell>BCa</cell></row><row><cell>Sloan 11</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Barnholtz</cell><cell>2014</cell><cell>USA</cell><cell>Africa</cell><cell>PB</cell><cell>737</cell><cell>658</cell><cell cols="4">161 390 186 170 339 149</cell><cell>Illumina</cell><cell cols="2">2.615 0.106</cell><cell>BCa</cell></row><row><cell>Sloan 12</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Butt</cell><cell>2012</cell><cell>Sweden</cell><cell>Caucasian</cell><cell>PB</cell><cell>678</cell><cell>1355</cell><cell cols="4">360 250 68 637 573 145</cell><cell>Sequenom</cell><cell cols="2">6.067 0.014</cell><cell>BCa</cell></row><row><cell>Gong</cell><cell>2016</cell><cell>China</cell><cell>Asian</cell><cell>HB</cell><cell>479</cell><cell>203</cell><cell>181 235 63</cell><cell>79</cell><cell>96</cell><cell>28</cell><cell>TaqMan</cell><cell cols="2">0.953 0.329</cell><cell>LC</cell></row><row><cell>Yin</cell><cell>2018</cell><cell>China</cell><cell>Asian</cell><cell>PB</cell><cell>556</cell><cell>395</cell><cell cols="4">161 266 129 140 185 70</cell><cell>Illumina</cell><cell cols="2">0.889 0.346</cell><cell>LC</cell></row><row><cell>Wu</cell><cell>2019</cell><cell>China</cell><cell>Asian</cell><cell>HB</cell><cell>359</cell><cell>1190</cell><cell cols="4">134 185 40 422 560 208</cell><cell>TaqMan</cell><cell cols="2">4.072 0.044</cell><cell>HCC</cell></row><row><cell>Yang</cell><cell>2019</cell><cell>China</cell><cell>Asian</cell><cell>HB</cell><cell>431</cell><cell>431</cell><cell cols="4">152 213 66 171 190 70</cell><cell>PCR</cell><cell cols="2">0.372 0.542</cell><cell>BC</cell></row><row><cell>Yin</cell><cell>2018</cell><cell>China</cell><cell>Asian</cell><cell>HB</cell><cell>556</cell><cell>395</cell><cell cols="4">161 266 129 140 185 70</cell><cell>Illumina</cell><cell cols="2">0.889 0.346</cell><cell>LC</cell></row><row><cell>6</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_RxuPYsG"><s xml:id="_ZfqK2bQ">PLOS ONE | https://doi.org/10.1371/journal.pone.0254943July</s><s xml:id="_cA8jd8g">26, 2021</s></p></note>
		</body>
		<back>


			<div type="funding">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_KpgVC64"><p xml:id="_XSZMrg4"><s xml:id="_WnEZpNR">The authors received no specific funding for this work.</s></p></div>
			</div>


			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_g3BZznx"><p xml:id="_e7uNSuw"><s xml:id="_nDXs4hy">All relevant data are within the manuscript and its Supporting Information files.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_RRtcfHv">Sensitivity analysis</head><p xml:id="_ZZznv2w"><s xml:id="_fQuMj5Z">Sensitivity analysis was carried out by removing single eligible study sequentially to detect individual study's influence on the pooled results.</s><s xml:id="_EnjTgkK">According to the results, no single study was found affect the pooled OR in the allele model, suggesting a statistically robust results (Fig <ref type="figure">7</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_dc2c9bX">Publication bias</head><p xml:id="_b6SEUkA"><s xml:id="_QsJY3tw">The Begg's funnel plot and Egger's test were utilized in the selected literature.</s><s xml:id="_SPUjDuC">With the symmetrical shapes of funnel plots shown in</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_xKn4Mc8">Trial sequential analysis results</head><p xml:id="_3te4R7c"><s xml:id="_8cnW9vA">In this meta-analysis, Fig <ref type="figure">9</ref> showed that the cumulative Z-curve of all the H19 mutations investigated either crossed the trial sequential monitoring boundary or exceeded the required information size, indicating that the results about the associations between LncRNA H19 polymorphic variants (rs2839698 G&gt;A, rs217727 G&gt;A, rs2107425 C&gt;T, rs2735971 A&gt;G and rs3024270 C&gt;G) and the susceptibility to cancer were firm evidence of effect.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_MfRpSu9">Cancer statistics</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jemal</surname></persName>
		</author>
		<idno type="DOI">10.3322/caac.21551</idno>
		<ptr target="https://doi.org/10.3322/caac.21551PMID:30620402" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_pgrpajA">CA Cancer J Clin</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page">7</biblScope>
			<date type="published" when="2019">2019. 2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Siegel R. L., Miller K. D. &amp; Jemal A., Cancer statistics, 2019. CA Cancer J Clin 69 7 (2019). https://doi. org/10.3322/caac.21551 PMID: 30620402</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_eWN7fjb">Quantitative assessment of polymorphisms in H19 lncRNA and cancer risk: a meta-analysis of 13,392 cases and 18,893 controls</title>
		<author>
			<persName><forename type="first">M</forename><surname>Chu</surname></persName>
		</author>
		<idno type="DOI">10.18632/oncotarget.12530</idno>
		<ptr target="https://doi.org/10.18632/oncotarget.12530PMID:27732938" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_RJDN5MK">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">78631</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chu M. et al., Quantitative assessment of polymorphisms in H19 lncRNA and cancer risk: a meta-analy- sis of 13,392 cases and 18,893 controls. Oncotarget 7 78631 (2016). https://doi.org/10.18632/ oncotarget.12530 PMID: 27732938</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_3EwXk3n">LncRNADisease: a database for long-non-coding RNA-associated diseases</title>
		<author>
			<persName><forename type="first">G</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1093/nar/gks1099</idno>
		<ptr target="https://doi.org/10.1093/nar/gks1099PMID:23175614" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_akBfMAu">NUCLEIC ACIDS RES</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page">983</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>D</note>
	<note type="raw_reference">Chen G. et al., LncRNADisease: a database for long-non-coding RNA-associated diseases. NUCLEIC ACIDS RES 41 D983 (2013). https://doi.org/10.1093/nar/gks1099 PMID: 23175614</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_FbFNMmy">Oncofetal H19 RNA promotes tumor metastasis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Matouk</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbamcr.2014.03.023</idno>
		<idno type="PMID">24703882</idno>
		<ptr target="https://doi.org/10.1016/j.bbamcr.2014.03.023" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_f47NarQ">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1843</biblScope>
			<biblScope unit="page">1414</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Matouk I. J. et al., Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys Acta 1843 1414 (2014). https://doi.org/10.1016/j.bbamcr.2014.03.023 PMID: 24703882</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_c6P7Zb7">LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2019.11.016</idno>
		<idno type="PMID">31711642</idno>
		<ptr target="https://doi.org/10.1016/j.bbrc.2019.11.016" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_uEMHB8r">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">521</biblScope>
			<biblScope unit="page">887</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yan J. et al., LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells. Biochem Biophys Res Commun 521 887 (2020). https://doi.org/10. 1016/j.bbrc.2019.11.016 PMID: 31711642</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_8uBShe8">LncRNA LINC00163 upregulation suppresses lung cancer development though transcriptionally increasing TCF21 expression</title>
		<author>
			<persName><forename type="first">X</forename><surname>Guo</surname></persName>
		</author>
		<idno type="PMID">30662806</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2aYddpv">AM J CANCER RES</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">2494</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guo X. et al., LncRNA LINC00163 upregulation suppresses lung cancer development though transcrip- tionally increasing TCF21 expression. AM J CANCER RES 8 2494 (2018). PMID: 30662806</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_ASW8bCh">Long noncoding RNA ZEB1-AS1 promotes the tumorigenesis of glioma cancer cells by modulating the miR-200c/141-ZEB1 axis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Meng</surname></persName>
		</author>
		<idno type="PMID">30662595</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JAFkGSM">AM J TRANSL RES</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">3395</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Meng L. et al., Long noncoding RNA ZEB1-AS1 promotes the tumorigenesis of glioma cancer cells by modulating the miR-200c/141-ZEB1 axis. AM J TRANSL RES 10 3395 (2018). PMID: 30662595</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_unU2pfW">The H19 non-coding RNA is essential for human tumor growth</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Matouk</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0000845</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0000845PMID:17786216" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_KkkyXEh">PLOS ONE</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">845</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Matouk I. J. et al., The H19 non-coding RNA is essential for human tumor growth. PLOS ONE 2 e845 (2007). https://doi.org/10.1371/journal.pone.0000845 PMID: 17786216</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_ZNc9A7M">Oncofetal splice-pattern of the human H19 gene</title>
		<author>
			<persName><forename type="first">I</forename><surname>Matouk</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2004.04.117</idno>
		<idno type="PMID">15147959</idno>
		<ptr target="https://doi.org/10.1016/j.bbrc.2004.04.117" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_wy7WpTN">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">318</biblScope>
			<biblScope unit="page">916</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Matouk I. et al., Oncofetal splice-pattern of the human H19 gene. Biochem Biophys Res Commun 318 916 (2004). https://doi.org/10.1016/j.bbrc.2004.04.117 PMID: 15147959</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_jGdTWUM">Molecular mechanisms of long noncoding RNAs</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Chang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.molcel.2011.08.018</idno>
		<idno type="PMID">21925379</idno>
		<ptr target="https://doi.org/10.1016/j.molcel.2011.08.018" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BCStwCy">MOL CELL</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page">904</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang K. C. &amp; Chang H. Y., Molecular mechanisms of long noncoding RNAs. MOL CELL 43 904 (2011). https://doi.org/10.1016/j.molcel.2011.08.018 PMID: 21925379</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_Rk2jqGE">Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer</title>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.1111/febs.13741</idno>
		<ptr target="https://doi.org/10.1111/febs.13741PMID:27093644" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_wkH3psb">FEBS J</title>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="page">2326</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Liu L. et al., Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer. FEBS J 283 2326 (2016). https://doi.org/10.1111/febs.13741 PMID: 27093644</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_bmAaTXV">Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression</title>
		<author>
			<persName><forename type="first">M</forename><surname>Luo</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.canlet.2013.01.033</idno>
		<idno type="PMID">23354591</idno>
		<ptr target="https://doi.org/10.1016/j.canlet.2013.01.033" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_FM3DmtP">CANCER LETT</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="page">213</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Luo M. et al., Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. CANCER LETT 333 213 (2013). https://doi.org/10.1016/j. canlet.2013.01.033 PMID: 23354591</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_fnHMms6">Significant association between functional microRNA polymorphisms and head and neck cancer susceptibility: a comprehensive meta-analysis</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Niu</surname></persName>
		</author>
		<idno type="DOI">10.1038/srep12972</idno>
		<ptr target="https://doi.org/10.1038/srep12972PMID:26277865" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_y2eJyCx">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">12972</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Niu Y. M. et al., Significant association between functional microRNA polymorphisms and head and neck cancer susceptibility: a comprehensive meta-analysis. Sci Rep 5 12972 (2015). https://doi.org/10. 1038/srep12972 PMID: 26277865</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_9382EDy">Association of lncRNA H19 rs217727 polymorphism and cancer risk in the Chinese population: a meta-analysis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
		<idno type="DOI">10.18632/oncotarget.10936</idno>
		<ptr target="https://doi.org/10.18632/oncotarget.10936PMID:27486980" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_pqNMk4G">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">59580</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lu Y. et al., Association of lncRNA H19 rs217727 polymorphism and cancer risk in the Chinese popula- tion: a meta-analysis. Oncotarget 7 59580 (2016). https://doi.org/10.18632/oncotarget.10936 PMID: 27486980</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_nWGB4PQ">Association of the study between LncRNA-H19 gene polymorphisms with the risk of breast cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Abdollahzadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ghorbian</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcla.22826</idno>
		<ptr target="https://doi.org/10.1002/jcla.22826PMID:30485527" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_PfX6phA">J CLIN LAB ANAL</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page">22826</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abdollahzadeh S. &amp; Ghorbian S., Association of the study between LncRNA-H19 gene polymorphisms with the risk of breast cancer. J CLIN LAB ANAL 33 e22826 (2019). https://doi.org/10.1002/jcla.22826 PMID: 30485527</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_aPJbxpX">SNP rs2071095 in LincRNA H19 is associated with breast cancer risk</title>
		<author>
			<persName><forename type="first">P</forename><surname>Cui</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10549-018-4814-y</idno>
		<ptr target="https://doi.org/10.1007/s10549-018-4814-yPMID:29737472" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_fBTseRk">Breast Cancer Res Treat</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="page">161</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cui P. et al., SNP rs2071095 in LincRNA H19 is associated with breast cancer risk. Breast Cancer Res Treat 171 161 (2018). https://doi.org/10.1007/s10549-018-4814-y PMID: 29737472</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_4NMHFU6">Association of lncRNA H19 Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.3390/genes10070506</idno>
		<ptr target="https://doi.org/10.3390/genes10070506PMID:31277475" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_z538PrP">Genes (Basel)</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wu E. R. et al., Association of lncRNA H19 Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma. Genes (Basel) 10 (2019). https://doi.org/10.3390/genes10070506 PMID: 31277475</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_UVj332M">Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Yang</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijerph16081322</idno>
		<ptr target="https://doi.org/10.3390/ijerph16081322PMID:31013794" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_RjPb22B">Int J Environ Res Public Health</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yang P. J. et al., Effects of Long Noncoding RNA H19 Polymorphisms on Urothelial Cell Carcinoma Development. Int J Environ Res Public Health 16 (2019). https://doi.org/10.3390/ijerph16081322 PMID: 31013794</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_9fZmwzN">Association between H19 polymorphisms and NSCLC risk in a Chinese Population</title>
		<author>
			<persName><forename type="first">G</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="PMID">31424642</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Uqeh7g9">J BUON</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">913</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang G., Liu Q., Cui K., Ma A. &amp; Zhang H., Association between H19 polymorphisms and NSCLC risk in a Chinese Population. J BUON 24 913 (2019). PMID: 31424642</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_bh2HKbG">A systematic review and meta-analysis of the association between long noncoding RNA polymorphisms and cancer risk</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Lv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yuan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mrrev.2016.10.002</idno>
		<idno type="PMID">28342449</idno>
		<ptr target="https://doi.org/10.1016/j.mrrev.2016.10.002" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_stUUJ6G">Mutat Res</title>
		<imprint>
			<biblScope unit="volume">771</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lv Z., Xu Q. &amp; Yuan Y., A systematic review and meta-analysis of the association between long non- coding RNA polymorphisms and cancer risk. Mutat Res 771 1 (2017). https://doi.org/10.1016/j.mrrev. 2016.10.002 PMID: 28342449</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_4kgpEXa">Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese population</title>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.18632/oncotarget.8330</idno>
		<ptr target="https://doi.org/10.18632/oncotarget.8330PMID:27027436" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_B8AbezC">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">25470</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li S. et al., Association of genetic variants in lncRNA H19 with risk of colorectal cancer in a Chinese pop- ulation. Oncotarget 7 25470 (2016). https://doi.org/10.18632/oncotarget.8330 PMID: 27027436</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_fRmt9KN">Polymorphisms in the H19 gene and the risk of bladder cancer</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Verhaegh</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.eururo.2008.01.060</idno>
		<idno type="PMID">18262338</idno>
		<ptr target="https://doi.org/10.1016/j.eururo.2008.01.060" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_wTcxZeB">EUR UROL</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page">1118</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Verhaegh G. W. et al., Polymorphisms in the H19 gene and the risk of bladder cancer. EUR UROL 54 1118 (2008). https://doi.org/10.1016/j.eururo.2008.01.060 PMID: 18262338</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_XCjZE6e">Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Gong</surname></persName>
		</author>
		<idno type="DOI">10.1038/aps.2016.164</idno>
		<idno type="PMID">28260796</idno>
		<ptr target="https://doi.org/10.1038/aps.2016.164" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_UnKGyr2">ACTA PHARMACOL SIN</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page">581</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gong W. J. et al., Association between well-characterized lung cancer lncRNA polymorphisms and plat- inum-based chemotherapy toxicity in Chinese patients with lung cancer. ACTA PHARMACOL SIN 38 581 (2017). https://doi.org/10.1038/aps.2016.164 PMID: 28260796</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_pRp253h">rs1859168 A &gt; C polymorphism regulates HOTTIP expression and reduces risk of pancreatic cancer in a Chinese population</title>
		<author>
			<persName><forename type="first">P</forename><surname>Hu</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12957-017-1218-0</idno>
		<ptr target="https://doi.org/10.1186/s12957-017-1218-0PMID:28818070" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_rEeeUFH">WORLD J SURG ONCOL</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">155</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hu P. et al., rs1859168 A &gt; C polymorphism regulates HOTTIP expression and reduces risk of pancre- atic cancer in a Chinese population. WORLD J SURG ONCOL 15 155 (2017). https://doi.org/10.1186/ s12957-017-1218-0 PMID: 28818070</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_AGUmT6h">The HOTAIR, PRNCR1 and POLR2E polymorphisms are associated with cancer risk: a meta-analysis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Chu</surname></persName>
		</author>
		<idno type="DOI">10.18632/oncotarget.14920</idno>
		<ptr target="https://doi.org/10.18632/oncotarget.14920PMID:28159929" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_yaQhDGX">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">43271</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chu H. et al., The HOTAIR, PRNCR1 and POLR2E polymorphisms are associated with cancer risk: a meta-analysis. Oncotarget 8 43271 (2017). https://doi.org/10.18632/oncotarget.14920 PMID: 28159929</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_aJS8guV">Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Gong</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13277-015-4497-5</idno>
		<ptr target="https://doi.org/10.1007/s13277-015-4497-5PMID:26729200" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_EN2k87r">Tumour Biol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page">8349</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gong W. J. et al., Association of well-characterized lung cancer lncRNA polymorphisms with lung can- cer susceptibility and platinum-based chemotherapy response. Tumour Biol 37 8349 (2016). https:// doi.org/10.1007/s13277-015-4497-5 PMID: 26729200</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_73jxp2y">Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Hua</surname></persName>
		</author>
		<idno type="DOI">10.1093/mutage/gew018</idno>
		<ptr target="https://doi.org/10.1093/mutage/gew018PMID:27091055" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_sBKyB8s">MUTAGENESIS</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page">531</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hua Q. et al., Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chi- nese population. MUTAGENESIS 31 531 (2016). https://doi.org/10.1093/mutage/gew018 PMID: 27091055</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_VtFYHGR">Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Xia</surname></persName>
		</author>
		<idno type="DOI">10.1097/md.0000000000002771</idno>
		<ptr target="https://doi.org/10.1097/MD.0000000000002771PMID:26886624" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BUQe4Jq">Medicine</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page">2771</biblScope>
			<date type="published" when="2016">2016</date>
			<pubPlace>Baltimore)</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Xia Z. et al., Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population. Medicine (Baltimore) 95 e2771 (2016). https://doi.org/10.1097/ MD.0000000000002771 PMID: 26886624</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_wgqK9aM">The association of polymorphisms in lncRNA-H19 with hepatocellular cancer risk and prognosis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Yang</surname></persName>
		</author>
		<idno type="DOI">10.1042/bsr20171652</idno>
		<ptr target="https://doi.org/10.1042/BSR20171652PMID:29511035" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_JXQUFbA">Biosci Rep</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yang M. L. et al., The association of polymorphisms in lncRNA-H19 with hepatocellular cancer risk and prognosis. Biosci Rep 38 (2018). https://doi.org/10.1042/BSR20171652 PMID: 29511035</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_66Se93f">Polymorphisms in the H19 gene and the risk of lung Cancer among female never smokers in Shenyang, China</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhou</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12885-018-4795-6</idno>
		<ptr target="https://doi.org/10.1186/s12885-018-4795-6PMID:30219045" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_K3YEbAW">BMC CANCER</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">893</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yin Z., Cui Z., Li H., Li J. &amp; Zhou B., Polymorphisms in the H19 gene and the risk of lung Cancer among female never smokers in Shenyang, China. BMC CANCER 18 893 (2018). https://doi.org/10.1186/ s12885-018-4795-6 PMID: 30219045</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_nKDHaGY">LncRNA H19 polymorphisms associated with the risk of OSCC in Chinese population</title>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">Y</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<idno type="PMID">28975993</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dhZd7FV">Eur Rev Med Pharmacol Sci</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">3770</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guo Q. Y., Wang H. &amp; Wang Y., LncRNA H19 polymorphisms associated with the risk of OSCC in Chi- nese population. Eur Rev Med Pharmacol Sci 21 3770 (2017). PMID: 28975993</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_PQdZKHJ">Association between H19 polymorphisms and osteosarcoma risk</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>He</surname></persName>
		</author>
		<idno type="PMID">28975992</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_82hfmfn">Eur Rev Med Pharmacol Sci</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">3775</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">He T. D. et al., Association between H19 polymorphisms and osteosarcoma risk. Eur Rev Med Pharma- col Sci 21 3775 (2017). PMID: 28975992</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_Ejv8SCJ">Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Safari</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.gene.2019.03.036</idno>
		<idno type="PMID">30910558</idno>
		<ptr target="https://doi.org/10.1016/j.gene.2019.03.036" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_VpMqdNX">GENE</title>
		<imprint>
			<biblScope unit="volume">701</biblScope>
			<biblScope unit="page">121</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Safari M. R. et al., Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population. GENE 701 121 (2019). https://doi.org/10.1016/j.gene.2019.03.036 PMID: 30910558</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_7dfpQcw">Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Niu</surname></persName>
		</author>
		<idno type="DOI">10.23736/s0393-2249.18.03004-7</idno>
		<idno type="PMID">29595036</idno>
		<ptr target="https://doi.org/10.23736/S0393-2249.18.03004-7" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_5rX7WV7">MINERVA UROL NEFROL</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page">161</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li Z. &amp; Niu Y., Association between lncRNA H19 (rs217727, rs2735971 and rs3024270) polymorphisms and the risk of bladder cancer in Chinese population. MINERVA UROL NEFROL 71 161 (2019). https:// doi.org/10.23736/S0393-2249.18.03004-7 PMID: 29595036</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_c6HAkFQ">Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population</title>
		<author>
			<persName><forename type="first">C</forename><surname>Yang</surname></persName>
		</author>
		<idno type="DOI">10.18632/oncotarget.3840</idno>
		<ptr target="https://doi.org/10.18632/oncotarget.3840PMID:25944697" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_sfxWRUv">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">15311</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yang C. et al., Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population. Oncotarget 6 15311 (2015). https://doi.org/10.18632/oncotarget.3840 PMID: 25944697</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_wJc88Rh">Genetic predisposition, parity, age at first childbirth and risk for breast cancer</title>
		<author>
			<persName><forename type="first">S</forename><surname>Butt</surname></persName>
		</author>
		<idno type="DOI">10.1186/1756-0500-5-414</idno>
		<ptr target="https://doi.org/10.1186/1756-0500-5-414PMID:22867275" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_nXyNEy6">BMC Res Notes</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">414</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Butt S. et al., Genetic predisposition, parity, age at first childbirth and risk for breast cancer. BMC Res Notes 5 414 (2012). https://doi.org/10.1186/1756-0500-5-414 PMID: 22867275</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_qnf6uPQ">FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Barnholtz-Sloan</surname></persName>
		</author>
		<idno type="DOI">10.1093/carcin/bgq128</idno>
		<ptr target="https://doi.org/10.1093/carcin/bgq128PMID:20554749" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_xcgnFBE">CARCINOGENESIS</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page">1417</biblScope>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Barnholtz-Sloan J. S. et al., FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. CARCINOGENESIS 31 1417 (2010). https://doi.org/10.1093/carcin/bgq128 PMID: 20554749</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_H6QmdTS">Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer</title>
		<author>
			<persName><forename type="first">L</forename><surname>Quaye</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0005983</idno>
		<idno type="PMID">19543528</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0005983" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_awFBw7G">PLOS ONE</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">5983</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Quaye L. et al., Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer. PLOS ONE 4 e5983 (2009). https://doi.org/10. 1371/journal.pone.0005983 PMID: 19543528</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_GmqJhnp">Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Song</surname></persName>
		</author>
		<idno type="DOI">10.1093/hmg/ddp138</idno>
		<ptr target="https://doi.org/10.1093/hmg/ddp138PMID:19304784" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_aYDxb5Q">HUM MOL GENET</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">2297</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Song H. et al., Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. HUM MOL GENET 18 2297 (2009). https://doi. org/10.1093/hmg/ddp138 PMID: 19304784</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_EDVsX5U">Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists</title>
		<author>
			<persName><forename type="first">P</forename><surname>Bhatti</surname></persName>
		</author>
		<idno type="DOI">10.1158/1055-9965.epi-08-0300</idno>
		<idno type="PMID">18708391</idno>
		<ptr target="https://doi.org/10.1158/1055-9965.EPI-08-0300" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_BSShx32">Cancer Epidemiol Biomarkers Prev</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">2007</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bhatti P. et al., Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists. Cancer Epidemiol Biomarkers Prev 17 2007 (2008). https://doi.org/10.1158/ 1055-9965.EPI-08-0300 PMID: 18708391</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_zR9w5YA">Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Lin</surname></persName>
		</author>
		<idno type="DOI">10.2147/ott.s127962</idno>
		<idno type="PMID">28919786</idno>
		<ptr target="https://doi.org/10.2147/OTT.S127962" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_3F47GfW">Onco Targets Ther</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">4369</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lin Y. et al., Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population. Onco Targets Ther 10 4369 (2017). https://doi.org/10.2147/OTT. S127962 PMID: 28919786</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_xfrn6X3">Association between H19 SNP rs217727 and lung cancer risk in a Chinese population: a case control study</title>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12881-018-0573-1</idno>
		<ptr target="https://doi.org/10.1186/s12881-018-0573-1PMID:30071841" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZeakuUy">BMC MED GENET</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page">136</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li L. et al., Association between H19 SNP rs217727 and lung cancer risk in a Chinese population: a case control study. BMC MED GENET 19 136 (2018). https://doi.org/10.1186/s12881-018-0573-1 PMID: 30071841</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_TgbQHSz">LncRNA H19 gene rs2839698 polymorphism is associated with a decreased risk of colorectal cancer in a Chinese Han population: A case-control study</title>
		<author>
			<persName><forename type="first">B</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jia</surname></persName>
		</author>
		<idno type="DOI">10.1002/jcla.23311</idno>
		<ptr target="https://doi.org/10.1002/jcla.23311PMID:32207861" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_g8kPf2R">J CLIN LAB ANAL</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page">23311</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yu B., Chen J., Hou C., Zhang L. &amp; Jia J., LncRNA H19 gene rs2839698 polymorphism is associated with a decreased risk of colorectal cancer in a Chinese Han population: A case-control study. J CLIN LAB ANAL 34 e23311 (2020). https://doi.org/10.1002/jcla.23311 PMID: 32207861</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_R6gzPJb">Correlation between polymorphisms in IGF2/H19 gene locus and epithelial ovarian cancer risk in Chinese population</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ygeno.2020.02.002</idno>
		<idno type="PMID">32045670</idno>
		<ptr target="https://doi.org/10.1016/j.ygeno.2020.02.002" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_fab9Agg">GENOMICS</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page">2510</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhang H. B., Zeng Y., Li T. L. &amp; Wang G., Correlation between polymorphisms in IGF2/H19 gene locus and epithelial ovarian cancer risk in Chinese population. GENOMICS 112 2510 (2020). https://doi.org/ 10.1016/j.ygeno.2020.02.002 PMID: 32045670</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_4kftAvX">The H19 Long non-coding RNA in cancer initiation, progression and metastasis-a proposed unifying theory</title>
		<author>
			<persName><forename type="first">E</forename><surname>Raveh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Matouk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gilon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hochberg</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12943-015-0458-2</idno>
		<ptr target="https://doi.org/10.1186/s12943-015-0458-2PMID:26536864" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_eDa7J7J">MOL CANCER</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">184</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Raveh E., Matouk I. J., Gilon M. &amp; Hochberg A., The H19 Long non-coding RNA in cancer initiation, pro- gression and metastasis-a proposed unifying theory. MOL CANCER 14 184 (2015). https://doi.org/ 10.1186/s12943-015-0458-2 PMID: 26536864</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_sWXK3az">Down-regulated long non-coding RNA H19 inhibits carcinogenesis of renal cell carcinoma</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.4149/neo%5F2015%5F049</idno>
		<ptr target="https://doi.org/10.4149/neo_2015_049PMID:25866221" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_32qT3tE">NEOPLASMA</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page">412</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang L. et al., Down-regulated long non-coding RNA H19 inhibits carcinogenesis of renal cell carci- noma. NEOPLASMA 62 412 (2015). https://doi.org/10.4149/neo_2015_049 PMID: 25866221</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_RpnZX4T">LncRNA H19 serves as a ceRNA and participates in non-small cell lung cancer development by regulating microRNA-107</title>
		<author>
			<persName><forename type="first">B</forename><surname>Qian</surname></persName>
		</author>
		<idno type="DOI">10.26355/eurrev%5F201809%5F15925</idno>
		<ptr target="https://doi.org/10.26355/eurrev_201809_15925PMID:30280776" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ercDHBu">Eur Rev Med Pharmacol Sci</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">5946</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Qian B. et al., LncRNA H19 serves as a ceRNA and participates in non-small cell lung cancer develop- ment by regulating microRNA-107. Eur Rev Med Pharmacol Sci 22 5946 (2018). https://doi.org/10. 26355/eurrev_201809_15925 PMID: 30280776</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_s3RVzBU">Significant association between lncRNA H19 polymorphisms and cancer susceptibility: a meta-analysis</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">F</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.18632/oncotarget.16658</idno>
		<ptr target="https://doi.org/10.18632/oncotarget.16658PMID:28404885" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_bn5d7MJ">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">45143</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li X. F. et al., Significant association between lncRNA H19 polymorphisms and cancer susceptibility: a meta-analysis. Oncotarget 8 45143 (2017). https://doi.org/10.18632/oncotarget.16658 PMID: 28404885</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_tSpHUA2">Gene expression arrays in cancer research: methods and applications</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Brentani</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.critrevonc.2004.12.006</idno>
		<idno type="PMID">15843092</idno>
		<ptr target="https://doi.org/10.1016/j.critrevonc.2004.12.006" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_umB2WZE">Crit Rev Oncol Hematol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page">95</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brentani R. R. et al., Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol 54 95 (2005). https://doi.org/10.1016/j.critrevonc.2004.12.006 PMID: 15843092</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_A8natN4">Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wetterslev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Thorlund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Brok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gluud</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jclinepi.2007.03.013</idno>
		<idno type="PMID">18083463</idno>
		<ptr target="https://doi.org/10.1016/j.jclinepi.2007.03.013" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_WbXnd96">J CLIN EPIDEMIOL</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page">64</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wetterslev J., Thorlund K., Brok J. &amp; Gluud C., Trial sequential analysis may establish when firm evi- dence is reached in cumulative meta-analysis. J CLIN EPIDEMIOL 61 64 (2008). https://doi.org/10. 1016/j.jclinepi.2007.03.013 PMID: 18083463</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_43keq29">How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Devereaux</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.38503.623646.8F</idno>
		<idno type="PMID">15996966</idno>
		<ptr target="https://doi.org/10.1136/bmj.38503.623646.8F" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_CX9UtSR">BMJ</title>
		<imprint>
			<biblScope unit="volume">331</biblScope>
			<biblScope unit="page">313</biblScope>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Devereaux P. J. et al., How strong is the evidence for the use of perioperative beta blockers in non-car- diac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 331 313 (2005). https://doi.org/10.1136/bmj.38503.623646.8F PMID: 15996966</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_HFt6w8d">Sex-Specific Association of Circulating Ferritin Level and Risk of Type 2 Diabetes: A Dose-Response Meta-Analysis of Prospective Studies</title>
		<author>
			<persName><forename type="first">L</forename><surname>Jiang</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2019-00495</idno>
		<ptr target="https://doi.org/10.1210/jc.2019-00495PMID:31074789" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_2sgRQxX">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page">4539</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jiang L. et al., Sex-Specific Association of Circulating Ferritin Level and Risk of Type 2 Diabetes: A Dose-Response Meta-Analysis of Prospective Studies. J Clin Endocrinol Metab 104 4539 (2019). https://doi.org/10.1210/jc.2019-00495 PMID: 31074789</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_X5h8BvB">Multi-trait analysis for genome-wide association study of five psychiatric disorders</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41398-020-00902-6</idno>
		<ptr target="https://doi.org/10.1038/s41398-020-00902-6PMID:32606422" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ahF6e5n">Transl Psychiatry</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">209</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wu Y. et al., Multi-trait analysis for genome-wide association study of five psychiatric disorders. Transl Psychiatry 10 209 (2020). https://doi.org/10.1038/s41398-020-00902-6 PMID: 32606422</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_SqSGtQD">Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Q</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>He</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.107.728857</idno>
		<idno type="PMID">17846284</idno>
		<ptr target="https://doi.org/10.1161/CIRCULATIONAHA.107.728857" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_yuvAEaG">CIRCULATION</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page">1356</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Xu M. Q., Ye Z., Hu F. B. &amp; He L., Quantitative assessment of the effect of angiotensinogen gene poly- morphisms on the risk of coronary heart disease. CIRCULATION 116 1356 (2007). https://doi.org/10. 1161/CIRCULATIONAHA.107.728857 PMID: 17846284</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_tup5C3v">Causal influences of neuroticism on mental health and cardiovascular disease</title>
		<author>
			<persName><forename type="first">F</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00439-021-02288-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PxBRuH9">HUM GENET</title>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhang F. et al., Causal influences of neuroticism on mental health and cardiovascular disease. HUM GENET (2021).</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_5HzzgsT">Genetic evidence suggests posttraumatic stress disorder as a subtype of major depressive disorder</title>
		<author>
			<persName><forename type="first">F</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci145942</idno>
		<ptr target="https://doi.org/10.1172/JCI145942PMID:33905376" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_UySQXvw">J CLIN INVEST</title>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhang F. et al., Genetic evidence suggests posttraumatic stress disorder as a subtype of major depres- sive disorder. J CLIN INVEST (2021). https://doi.org/10.1172/JCI145942 PMID: 33905376</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_ajAaz8A">Genetic support of a causal relationship between iron status and type 2 diabetes: a Mendelian randomization study</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1210/clinem/dgab454</idno>
		<ptr target="https://doi.org/10.1210/clinem/dgab454PMID:34147035" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_GUFXu4V">J Clin Endocrinol Metab</title>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang X. et al., Genetic support of a causal relationship between iron status and type 2 diabetes: a Men- delian randomization study. J Clin Endocrinol Metab (2021). https://doi.org/10.1210/clinem/dgab454 PMID: 34147035</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_zf2j8R3">Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Allemailem</surname></persName>
		</author>
		<idno type="PMID">34017579</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2Yap5ST">AM J TRANSL RES</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">3868</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Allemailem K. S. et al., Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics. AM J TRANSL RES 13 3868 (2021). PMID: 34017579</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_uS4pTpz">LEPR hypomethylation is significantly associated with gastric cancer in males</title>
		<author>
			<persName><forename type="first">H</forename><surname>Yu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.yexmp.2020.104493</idno>
		<idno type="PMID">32659237</idno>
		<ptr target="https://doi.org/10.1016/j.yexmp.2020.104493" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_AVV4EQ7">EXP MOL PATHOL</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page">104493</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yu H. et al., LEPR hypomethylation is significantly associated with gastric cancer in males. EXP MOL PATHOL 116 104493 (2020). https://doi.org/10.1016/j.yexmp.2020.104493 PMID: 32659237</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_G9Rargn">A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuroimage.2019.116459</idno>
		<idno type="PMID">31837471</idno>
		<ptr target="https://doi.org/10.1016/j.neuroimage.2019.116459" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_Vg5QypV">NEUROIMAGE</title>
		<imprint>
			<biblScope unit="volume">208</biblScope>
			<biblScope unit="page">116459</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Liu M. et al., A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer&apos;s disease. NEUROIMAGE 208 116459 (2020). https://doi.org/10.1016/j. neuroimage.2019.116459 PMID: 31837471</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_S9vJKaH">Immunodeficiency Promotes Adaptive Alterations of Host Gut Microbiome: An Observational Metagenomic Study in Mice</title>
		<author>
			<persName><forename type="first">S</forename><surname>Zheng</surname></persName>
		</author>
		<idno type="DOI">10.3389/fmicb.2019.02415</idno>
		<idno type="PMID">31781050</idno>
		<ptr target="https://doi.org/10.3389/fmicb.2019.02415" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_2tqWmtt">FRONT MICROBIOL</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">2415</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zheng S. et al., Immunodeficiency Promotes Adaptive Alterations of Host Gut Microbiome: An Observa- tional Metagenomic Study in Mice. FRONT MICROBIOL 10 2415 (2019). https://doi.org/10.3389/ fmicb.2019.02415 PMID: 31781050</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_QASPy34">The Processing, Gene Regulation, Biological Functions, and Clinical Relevance of N4-Acetylcytidine on RNA: A Systematic Review</title>
		<author>
			<persName><forename type="first">Jin</forename><forename type="middle">G</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.omtn.2020.01.037</idno>
		<idno type="PMID">32171170</idno>
		<ptr target="https://doi.org/10.1016/j.omtn.2020.01.037" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZShcMQc">Mol Ther Nucleic Acids</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page">13</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jin G., Xu M., Zou M. &amp; Duan S., The Processing, Gene Regulation, Biological Functions, and Clinical Relevance of N4-Acetylcytidine on RNA: A Systematic Review. Mol Ther Nucleic Acids 20 13 (2020). https://doi.org/10.1016/j.omtn.2020.01.037 PMID: 32171170</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
